Latest News

Landmark Petition to Reschedule Psilocybin filed with DEA

February 4, 2022 ( Newswire) Bipartisan Congressional support for allowing terminal patients to seek relief from anxiety and depression in alignment with ongoing international research on the effectiveness of psilocybin in mental health care

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *